Align Technology, Inc. (NasdaqGS: ALGN)

Former United States Securities and Exchange Commission attorney Willie Briscoe, founder of The Briscoe Law Firm, PLLC, announces that a federal class action lawsuit has been filed against Align Technology, Inc. (“Align” or “Company”) (NasdaqGS: ALGN) and several officers and directors for acts taken during the period of July 25, 2018 and October 24, 2018 (the “Class Period”).

Based upon the allegations in the class action, the firm is investigating additional legal claims against the officers and Board of Directors of Align.  If you are an affected Align shareholder and want to learn more about the lawsuit or join the action, contact Willie Briscoe at The Briscoe Law Firm, PLLC via email at shareholders@thebriscoelawfirm.com or call toll free at (888) 809-2750.  There is no cost or fee to you.

According to the complaint, the defendants are alleged to have violated certain provisions of the Securities Exchange Act of 1934.  Specifically, the complaint alleges, among other things, that defendants issued false and/or misleading statements and/or failed to disclose the following: (1) that the Company would offer higher discounts to promote Invisalign; (2) that the promotions would materially impact revenue; and (3) that, as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.

On October 24, 2018, Align announced its Q3 2018 financial results disclosing more than a 6% decrease in its Invisalign Average Selling Price. That same day, Align also announced that its Chief Marketing Officer would “reduce his responsibilities and transition to a part-time position.” When this news was revealed to the market, Align’s stock dropped 20%.

The Briscoe Law Firm, PLLC is a full-service business litigation, commercial transaction, and public advocacy firm with more than 20 years of experience in complex litigation and transactional matters.

AbbVie Inc. (NYSE: ABBV)

Former United States Securities and Exchange Commission attorney Willie Briscoe, founder of The Briscoe Law Firm, PLLC, announces that a federal class action lawsuit has been filed against AbbVie Inc. (“AbbVie” or “Company”) (NYSE: ABBV) and several officers and directors for acts taken during the period of October 25, 2013 and September 18, 2018 (the “Class Period”).

Based upon the allegations in the class action, the firm is investigating additional legal claims against the officers and Board of Directors of AbbVie. If you are an affected AbbVie shareholder and want to learn more about the lawsuit or join the action, contact Willie Briscoe at The Briscoe Law Firm, PLLC via email at shareholders@thebriscoelawfirm.com or call toll free at (888) 809-2750. There is no cost or fee to you.

According to the complaint, the defendants are alleged to have violated certain provisions of the Securities Exchange Act of 1934. Specifically, the complaint alleges, among other things, that defendants issued false and/or misleading statements and/or failed to disclose the following: (1) AbbVie’s strategy to increase the sales growth of HUMIRA was through illegal kickbacks and unlawful sales and marketing tactics; (2) such practices would lead to heightened scrutiny by State governments and agencies; and (3) as a result, AbbVie’s public statements were materially false and misleading at all relevant times. When this news was revealed to the market, the Company’s stock dropped significantly.

The Briscoe Law Firm, PLLC is a full-service business litigation, commercial transaction, and public advocacy firm with more than 20 years of experience in complex litigation and transactional matters.

Symantec Corporation (NasdaqGS: SYMC)

Former United States Securities and Exchange Commission attorney Willie Briscoe, founder of The Briscoe Law Firm, PLLC, announces that a federal class action lawsuit has been filed against Symantec Corporation (“Symantec” or “Company”) (NasdaqGS: SYMC) and several officers and directors for acts taken during the period of May 19, 2017 and May 10, 2018 (the “Class Period”).

Based upon the allegations in the class action, the firm is investigating additional legal claims against the officers and Board of Directors of Symantec. If you are an affected Symantec shareholder and want to learn more about the lawsuit or join the action, contact Willie Briscoe at The Briscoe Law Firm, PLLC via email at shareholders@thebriscoelawfirm.comor call toll free at (888) 809-2750. There is no cost or fee to you.

According to the complaint, the defendants are alleged to have violated certain provisions of the Securities Exchange Act of 1934. Specifically, the complaint alleges, among other things, that defendants issued false and/or misleading statements and/or failed to disclose the following: (1) Symantec’s internal controls over financial reporting were materially weak and deficient; (2) Symantec later disclosed “reporting of certain Non-GAAP measures including those that could impact executive compensation programs” would lead to heightened regulatory scrutiny by the SEC; and (3) as a result, Symantec’s public statements were materially false and misleading at all relevant times.

On May 10, 2018, after the market closed, Symantec disclosed that its Audit Committee had commenced an investigation “in connection with concerns raised by a former employee” and that the Company had advised the Securities and Exchange Commission (“SEC”) of the investigation. Symantec further disclosed that it was “unlikely that the investigation will be completed in time for the Company to file its annual report on Form 10-K for the fiscal year ended March 30, 2018, in a timely manner.” When this news was revealed to the market, the Company’s stock dropped significantly.

The Briscoe Law Firm, PLLC is a full service business litigation, commercial transaction, and public advocacy firm with more than 20 years of experience in complex litigation and transactional matters.

Myriad Gynetics, Inc. (NASDAQGS: MYGN)

Former United States Securities and Exchange Commission attorney Willie Briscoe, founder of The Briscoe Law Firm, PLLC, announces that a federal class action lawsuit has been filed against Myriad Genetics (“Myriad” or “Company”) (NasdaqGS: MYGN) and several officers and directors for acts taken during the period of August 13, 2014 and March 12, 2018 (the “Class Period”).

Based upon the allegations in the class action, the firm is investigating additional legal claims against the officers and Board of Directors of Myriad.  If you are an affected Myriad shareholder and want to learn more about the lawsuit or join the action, contact Willie Briscoe at The Briscoe Law Firm, PLLC via email at shareholders@thebriscoelawfirm.com or call toll free at (888) 809-2750.  There is no cost or fee to you.

In the complaint, the defendants are alleged to have violated certain provisions of the Securities Exchange Act of 1934.  Specifically, the complaint alleges, among other things, that defendants’ misrepresented and/or failed to disclose during the Class Period that: (i) Myriad was submitting false or otherwise improper claims for payment under Medicare and Medicaid for the company’s hereditary cancer testing; (ii) the foregoing conduct would foreseeably subject Myriad to heightened regulatory scrutiny and/or enforcement action; (iii) Myriad’s revenues from its hereditary cancer testing were in part the product of improper conduct and unlikely to be sustainable; and (iv) as a result, Myriad’s public statements were materially false and misleading at all relevant times.

On March 12, 2018, Myriad disclosed that it had received a subpoena from the Department of Health and Human Services, Office of Inspector General, in connection with “an investigation into possible false or otherwise improper claims submitted for payment under Medicare and Medicaid,” specifically relating to Myriad’s hereditary cancer testing. The subpoena covers a time period from January 1, 2014 through the date of the subpoena’s issuance. When this news was revealed to the market, the Company’s stock dropped significantly.

The Briscoe Law Firm, PLLC is a full service business litigation, commercial transaction, and public advocacy firm with more than 20 years of experience in complex litigation and transactional matters.

 

InnerWorkings, Inc. (NASDAQGS: INWK)

Former United States Securities and Exchange Commission attorney Willie Briscoe, founder of The Briscoe Law Firm, PLLC, announces that a federal class action lawsuit has been filed against Innerworkings, Inc. (“InnerWorkings” or “Company”) (NasdaqGS: INWK) and several officers and directors for acts taken during the period of August 11, 2015 and May 7, 2018 (the “Class Period”).

Based upon the allegations in the class action, the firm is investigating additional legal claims against the officers and Board of Directors of InnerWorkings.  If you are an affected InnerWorkings shareholder and want to learn more about the lawsuit or join the action, contact Willie Briscoe at The Briscoe Law Firm, PLLC via email at shareholders@thebriscoelawfirm.com or call toll free at (888) 809-2750.  There is no cost or fee to you.

According to the complaint, the defendants are alleged to have violated certain provisions of the Securities Exchange Act of 1934.  Specifically, the complaint alleges, among other things, that defendants issued false and/or misleading statements and/or failed to disclose the following: (1) InnerWorkings’ financial statements for the fiscal years ending December 31, 2017, 2016, and 2015 as well as all interim periods contained errors that required restating; and (2) InnerWorkings’ financial statements were materially false and misleading at all relevant times.  When this news was revealed to the market, the Company’s stock dropped significantly.

The Briscoe Law Firm, PLLC is a full service business litigation, commercial transaction, and public advocacy firm with more than 20 years of experience in complex litigation and transactional matters.

 

LongFin Corp. (NASDAQCM: LFIN)

Former United States Securities and Exchange Commission attorney Willie Briscoe, founder of The Briscoe Law Firm, PLLC, announces that a federal class action lawsuit has been filed against LongFin Corp. (“LongFin” or “Company”) (NasdaqCM: LFIN) and several officers and directors for acts taken during the period of December 15, 2017 and April 2, 2018 (the “Class Period”).

Based upon the allegations in the class action, the firm is investigating additional legal claims against the officers and Board of Directors of LongFin. If you are an affected LongFin shareholder and want to learn more about the lawsuit or join the action, contact Willie Briscoe at The Briscoe Law Firm, PLLC via email at shareholders@thebriscoelawfirm.com or call toll free at (888) 809-2750. There is no cost or fee to you.

According to the complaint, the defendants are alleged to have violated certain provisions of the Securities Exchange Act of 1934. Specifically, the complaint alleges, among other things, that defendants issued false and/or misleading statements and/or failed to disclose the following: (i) LongFin had misrepresented material facts about its business and operations, including the extent of its capabilities at its New York offices and the identity and qualifications of key employees; (ii) Longfin had material weaknesses in its operations and internal controls over financial reporting; (iii) Longfin was ineligible for inclusion in the Russell Indices; (iv) Longfin’s lack of profitability had imperiled its ability to continue as a going concern; and (v) as a result of the foregoing, Longfin’s financial statements and Defendants’ statements about Longfin’s business, operations, and prospects, were materially false and misleading at all relevant times.

On March 26, 2018, Citron Research posted a tweet on Twitter.com accusing the Company of inaccuracies in its financial reporting and fraud. The same day, FTSE Russell issued a statement announcing that Longfin would be removed from its global indices after market close on March 28, 2018, approximately 12 days after being added. Then, on March 27, 2018, CNBC published an article entitled “Longfin loses more than a third of its value after the controversial cryptocurrency stock is booted from the Russell 2000 index.” In the article, Meenavalli stated that Longfin would be taking legal action against Citron for its negative comments. Following each of these announcements, the Company’s stock dropped significantly.

The Briscoe Law Firm, PLLC is a full service business litigation, commercial transaction, and public advocacy firm with more than 20 years of experience in complex litigation and transactional matters.

Henry Schein, Inc. (NasdaqGS: HSIC)

Former United States Securities and Exchange Commission attorney Willie Briscoe, founder of The Briscoe Law Firm, PLLC, announces that a federal class action lawsuit has been filed against Henry Schein, Inc. (“Henry Schein” or “Company”) (NasdaqGS: HSIC) and several officers and directors for acts taken during the period of March 7, 2013 and February 12, 2018 (the “Class Period”).

Based upon the allegations in the class action, the firm is investigating additional legal claims against the officers and Board of Directors of Henry Schein. If you are an affected Henry Schein shareholder and want to learn more about the lawsuit or join the action, contact Willie Briscoe at The Briscoe Law Firm, PLLC via email at shareholders@thebriscoelawfirm.com or call toll free at (888) 809-2750. There is no cost or fee to you.

According to the complaint, the defendants are alleged to have violated certain provisions of the Securities Exchange Act of 1934. Specifically, the complaint alleges, among other things, that defendants issued false and/or misleading statements and/or failed to disclose the following: (1) Henry Schein was engaging in unethical, anti-competitive behavior through agreements with Benco Dental Supply Company and Patterson Companies, Inc., in violation of United States antitrust laws; (2) Henry Schein engaged in such behavior, in part, to help maintain profitability in a consolidating health care industry; (3) these violations of U.S. antitrust laws would result in heightened scrutiny by the federal government and a lawsuit filed by the Federal Trade Commission; (4) Henry Schein failed to maintain adequate internal controls; and (5) as a result, defendants’ statements about Henry Schein’s business, operations and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times. When this news was revealed to the market, the Company’s stock dropped significantly.

The Briscoe Law Firm, PLLC is a full service business litigation, commercial transaction, and public advocacy firm with more than 20 years of experience in complex litigation and transactional matters.

TrueCar, Inc. (NASDAQGS: TRUE)

Former United States Securities and Exchange Commission attorney Willie Briscoe, founder of The Briscoe Law Firm, PLLC, announces that a federal class action lawsuit has been filed against TrueCar, Inc. (“TrueCar” or “Company”) (NasdaqGS: TRUE) and several officers and directors for acts taken during the period of February 16, 2017 and November 6, 2017 (the “Class Period”).

Based upon the allegations in the class action, the firm is investigating additional legal claims against the officers and Board of Directors of TrueCar. If you are an affected TrueCar shareholder and want to learn more about the lawsuit or join the action, contact Willie Briscoe at The Briscoe Law Firm, PLLC via email at shareholders@thebriscoelawfirm.com or call toll free at (888) 809-2750. There is no cost or fee to you.

In the complaint, the defendants are alleged to have violated certain provisions of the Securities Exchange Act of 1934. Specifically, the complaint alleges, among other things, that defendants’ misrepresented and/or failed to disclose during the Class Period that: (1) United States Automobile Association (“USAA”), the largest source of TrueCar’s revenue, had been planning significant changes to its website that would have a material adverse effect on the volume of purchases generated by USAA; (2) USAA made significant changes to its website that would have a material adverse effect on the volume of purchases generated by USAA; (3) the changes to USAA’s website maintained by TrueCar caused a material adverse effect on the volume of purchases generated by USAA; and (4) as a result, defendants’ statements about TrueCar’s business, operations, and prospects were materially false and/or misleading and/or lacked a reasonable basis. When this news was revealed to the market, the Company’s stock dropped significantly.

The Briscoe Law Firm, PLLC is a full service business litigation, commercial transaction, and public advocacy firm with more than 20 years of experience in complex litigation and transactional matters.

Ulta Beauty, Inc. (NASDAQ: ULTA)

Former United States Securities and Exchange Commission attorney Willie Briscoe, founder of The Briscoe Law Firm, PLLC, announces that a federal class action lawsuit has been filed in the United States District Court, Northern District of Illinois, against Ulta Beauty, Inc. (“Ulta” or “Company”) (NASDAQ: ULTA) and several officers and directors for acts taken during the period of March 30, 2016 and February 23, 2018 (the “Class Period”).

Based upon the allegations in the class action, the firm is investigating additional legal claims against the officers and Board of Directors of Ulta. If you are an affected Ulta shareholder and want to learn more about the lawsuit or join the action, contact Willie Briscoe at The Briscoe Law Firm, PLLC via email at shareholders@thebriscoelawfirm.com or call toll free at (888) 809-2750. There is no cost or fee to you.

In the complaint, the defendants are alleged to have violated certain provisions of the Securities Exchange Act of 1934. Specifically, the complaint alleges, among other things, that defendants misrepresented and/or failed to disclose during the Class Period that: (i) Ulta was engaged in the widespread practice of repackaging returned cosmetics and re-shelving them alongside unblemished products to sell at full retail price; and (ii) that as a result of the foregoing, Ulta’s public statements were materially false and misleading at all relevant times. After the market closed on February 9, 2018, media outlets reported that a consumer class action lawsuit had been filed against Ulta, alleging that the Company engaged in the “widespread and surreptitious” practice of repacking returned cosmetics and re-shelving them alongside unblemished products to sell at full price. According to the consumer class action complaint, “dozens of other current and former Ulta employees from retail locations all over the country confirmed that substantially similar practices also occurred at the Ulta stores where they worked.”

On this news, Ulta’s share price fell $9.07, or 4.15%, to close at $209.48 on February 12, 2018, the following trading day. Then, on February 23, 2018, CBS News published a story entitled “Former Ulta Beauty employee says she felt pressured to resell used products,” reporting on statements made on Twitter by at least one former Ulta employee, to the effect that Ulta store managers frequently pressured its employees to clean and resell used products. When this news was revealed to the market, Ulta’s share price fell $8.18 or 3.94%, to close at $198.93 on February 26, 2018.

The Briscoe Law Firm, PLLC is a full service business litigation, commercial transaction, and public advocacy firm with more than 20 years of experience in complex litigation and transactional matters.

Acadia Healthcare Company, Inc. (NasdaqGS: ACHC)

Former United States Securities and Exchange Commission attorney Willie Briscoe, founder of The Briscoe Law Firm, PLLC, announces that a federal class action lawsuit has been filed against Acadia Healthcare Company, Inc. (“Acadia” or “Company”) (NasdaqGS: ACHC) and several officers and directors for acts taken during the period of February 23, 2017 and October 24, 2017 (the “Class Period”).

Based upon the allegations in the class action, the firm is investigating additional legal claims against the officers and Board of Directors of Acadia. If you are an affected Acadia shareholder and want to learn more about the lawsuit or join the action, contact Willie Briscoe at The Briscoe Law Firm, PLLC via email at shareholders@thebriscoelawfirm.com or call toll free at (888) 809-2750. There is no cost or fee to you.

According to the complaint, the defendants are alleged to have violated certain provisions of the Securities Exchange Act of 1934. Specifically, the complaint alleges, among other things, that Acadia materially misled the investing public, which had the effect of inflating the stock price of Acadia. Beginning on February 23, 2017, Acadia represented in its public filings and press releases that it was “the leading independent provider of mental health services in the U.K.” and that “favorable industry and legislative trends” gave the company a “competitive strength,” which would drive future growth and profitability. Acadia further misrepresented the extent of the its actual and projected 2017 revenue, earnings before interest, taxes, depreciation and amortization (“EBITA”) and earnings per share (“EPS”). With Acadia’s stock artificially inflated, its officers and directors sold over $143 million worth of Acadia stock through a continuous offering process. On October 24, 2017, Acadia issued a press release disclosing that its struggling U.K. facilities had missed the forecasts that defendants had stated to investors would be met throughout the year. The press release also reduced Acadia’s recently reaffirmed fiscal year 2017 guidance. Acadia stock dropped significantly immediately following this announcement.

The Briscoe Law Firm, PLLC is a full service business litigation, commercial transaction, and public advocacy firm with more than 20 years of experience in complex litigation and transactional matters.